New hope for bipolar depression? experimental drug enters Mid-Stage testing
Disease control
Recruiting now
This study is testing whether an investigational oral medication called LB-102 can help reduce depressive symptoms in adults with Bipolar I Disorder. About 320 participants will be randomly assigned to take either LB-102 or a placebo pill daily for six weeks. Researchers will mea…
Phase: PHASE2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC